Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
931.95
8.30 (0.90%) NATCO Pharma informs about issuance of duplicate share certificates
Date: 27-02-2023Pursuant to the Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 NATCO Pharma has informed that the company is in process of issuing duplicate share certificates in lieu of the originals thereof, stated to have been lost by the respective shareholder, Sumer Kawar (Folio No: 19358), further details are attached.
The above information is a part of company’s filings submitted to BSE.